Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD

Clinical trial NCT05962645 · COMPLETED

Trial details

NCT number: NCT05962645
Sponsor: Altesa Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COPD Respiratory Disease Lower Respiratory Disease Pulmonary Disease Healthy

Start date: 2023-05-19
Primary completion: 2023-12-12
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.